|
|
| | 4-((14-Amino-3,6,9,12-tetraoxatetradecyl)oxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione hydrochloride Basic information |
| Product Name: | 4-((14-Amino-3,6,9,12-tetraoxatetradecyl)oxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione hydrochloride | | Synonyms: | 4-((14-Amino-3,6,9,12-tetraoxatetradecyl)oxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione hydrochloride;1H-Isoindole-1,3(2H)-dione, 4-[(14-amino-3,6,9,12-tetraoxatetradec-1-yl)oxy]-2-(2,6-dioxo-3-piperidinyl)-, hydrochloride (1:1);4-(H2N-PEG5)-Thalidomide HCl | | CAS: | 2820929-03-9 | | MF: | C23H31N3O9.ClH | | MW: | 529.97 | | EINECS: | | | Product Categories: | Please select-Please select | | Mol File: | 2820929-03-9.mol |  |
| | 4-((14-Amino-3,6,9,12-tetraoxatetradecyl)oxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione hydrochloride Chemical Properties |
| form | Oil | | color | Colorless to yellow |
| | 4-((14-Amino-3,6,9,12-tetraoxatetradecyl)oxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione hydrochloride Usage And Synthesis |
| Uses | Thalidomide-O-PEG4-amine hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1]. | | IC 50 | Cereblon | | References | [1] Zhang NN, et al. A Thermostable mRNA Vaccine against COVID-19. Cell. 2020;182(5):1271-1283.e16. DOI:10.1016/j.cell.2020.07.024 |
| | 4-((14-Amino-3,6,9,12-tetraoxatetradecyl)oxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione hydrochloride Preparation Products And Raw materials |
|